PhD in Genome Editing & Gene Therapy
Earliest start date
We are looking for a Ph.D. student to join our therapeutic genome editing team, led by Dr. Ayal Hendel.
Our laboratory focuses on developing precise and efficient CRISPR genome editing as a curative therapy for genetic diseases. In particular, we are interested in developing an optimized CRISPR genome editing for gene therapy of hematopoietic inherited disorders such as severe combined immunodeficiency (SCID). Our research also focuses on applying CRISPR technology to treat malignancies using cancer immunotherapy.
The Hendel lab is specialized in a variety of cutting-edge technologies such as next-generation sequencing, flow cytometry, ex-vivo manipulation of stem and progenitor cells, viral vector design and hematopoietic stem cell transplantation into mice models. The Hendel lab has assembled a multidisciplinary team of collaborators who fuse the creativity of academics with clinical experience to create a highly supportive research environment necessary to abridge the bench-to-bedside gap.